Popular Articles
Revitol Cellulite Cream

Magnets For Migraines
New animal research suggests that a noninvasive therapy called transcranial magnetic stimulation (TMS) may help treat chronic migraines. Don't forget to buy zoloft online no prescription.

Tobramycin Inhalation Powder (TIP) Improved Lung Function In Cystic Fibrosis (CF) Patients With Respiratory Pseudomonas Aeruginosa (Pa) Infection
In a Phase III study, TIP, an inhaled investigational formulation of tobramycin, improved lung function (as measured by FEV1) in cystic fibrosis patients with Pseudomonas aeruginosa (Pa) infection, compared to placebo. The data, presented today at the American Thoracic Society (ATS) 2009 International Conference in San Diego, also demonstrated, with respect to secondary endpoints, that TIP decreased sputum Pa density, hospitalization and other antibiotic use in these patients versus placebo.

generic viagra online


News of the day
Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers
Epeius Biotechnologies stuns the medical and scientific communities with a dramatic demonstration of single-agent efficacy with its lead product, Rexin-G, for metastatic cancer. The landmark article (accessible online as of June 16, 2009 in Molecular Therapy, the Official Journal of The American Society of Gene Therapy, documents the results of two related studies using Rexin-G, a tumor-targeted anti-cancer agent designed to seek-out and destroy metastatic cancers that have spread throughout the body, while sparing normal cells and healthy tissues and organs. Following the FDA"s designation of Rexin-G as an Orphan Drug for the treatment of soft tissue sarcoma and osteosarcoma in 2008, the results of these two independent studies represent a major step toward gaining Accelerated Approval of Rexin-G for osteosarcoma in the United States.
Cardiovascular

New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals To Access Electronic Medical Records (EMR) Directly At The Point Of Care

InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced the introduction of a new mobility offering for healthcare providers, the InfoLogix M24 mobile clinical assistant: a powerful mobile computing solution that enables medical professionals to access critical patient information at the point-of-care. The innovative InfoLogix M24 mobile clinical assistant is the missing link between busy clinicians who are always on the move and the valuable patient data that resides in hospital information systems. With the InfoLogix M24, medical professionals can easily input vital information, access a patient"s Electronic Medical Record (EMR), verify a patient"s correct medication and dosage, and view and capture diagnostic medical images, all directly at the bedside through an ergonomically-designed mobile device. The InfoLogix M24 is built upon the Intel(R) mobile clinical assistant reference architecture, which is designed specifically for healthcare and the rigors of the clinical environment, including integrated technologies that support the "five rights" of medication administration and provide more streamlined and efficient workflows. Additionally, the InfoLogix M24( )features an array of cutting-edge technologies such as a bar code scanner, a Radio Frequency Identification (RFID) reader, a fingerprint reader, a webcam, and a microphone array. These innovative tools enable hospital staff to access valuable patient data quickly and easily which can help reduce the number of errors and allow clinicians to spend more quality time with patients. "Given that one of the nation"s top priorities is reducing healthcare costs by eliminating inefficiencies, we believe new technology is a key ingredient necessary to achieve this important goal," noted David Gulian, President and CEO of InfoLogix. "The InfoLogix M24 mobile clinical assistant is a critical piece of the puzzle for hospitals that are looking to provide higher quality patient care while at the same time reducing the cost of care. It"s an affordable solution that allows medical professionals to have comprehensive patient information at their fingertips, delivered through a lightweight, portable and ergonomically-designed device." "In partnership with clinicians worldwide, the Mobile Clinical Assistant platform is revolutionizing the way that hospitals are delivering care to their patients, by enabling more informed and immediate decisions at the point of care, helping to reduce medication administration errors, and easing workloads," said Louis Burns, vice president and general manager of Intel"s Digital Health Group. "By serving over 1,500 hospitals across North America with mobility solutions, InfoLogix has a unique understanding of how mobility challenges affect healthcare organizations, and we"re pleased that InfoLogix chose to base the new InfoLogix M24 on the MCA reference design." About InfoLogix, Inc. InfoLogix is a leading provider of enterprise mobility solutions for the healthcare and commercial industries. InfoLogix uses the industry"s most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, MultiCare Health System and Stanford School of Medicine. InfoLogix is a publicly-traded company (Nasdaq: IFLG). InfoLogix, Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):